The European Allergen Manufacturers Group
is an association of companies with mutual interests
in the manufacturing and delivery of allergen extracts
for the diagnosis, treatment and prevention
of allergic diseases.

IMMUNOTHERAPY!
To consider early in allergy and as a first choice?

“Conventionally, SIT is used relatively late in the treatment. Nevertheless, according to the ARIA group, SIT should be initiated early in the disease process to provide immediate as well as long-lasting symptomatic relief, to reduce the risk of side effects and to prevent the further development of severe disease (ARIA)”.

C. Bachert in his presentation at the World Allergy Congress, Munich, 28 June 2005

for further quotations click here







EAMG
Place of business: Klein Heiligland 45, NL- 2011 EC Haarlem - The Netherlands Head office: Krokushaven 18, DK - 2765 Smørum - Denmark
Phone: +45 4468 0421
E-mail: info@eamg.com